References
- Acartu¨rk, F. and Robinson, J.R. (1996) “Vaginal permeability and enzymatic activity studies in normal and ovariectomized rabbits”, Pharm. Res. 13, 779–783.
- Aoyagi, N., Kaniwa, N. and Uchiyama, M. (1995) “Inter-labaratory reproducibility of release tests for suppositories”, Drug Dev. Ind. Pharm. 21, 175–183.
- Asikoglu, M., Ertan, G. and Cos¸ar, G. (1995) “The release of isoconazole nitrate from different suppository bases: in-vitro dissolution, physicochemical and microbiological studies”, J. Pharm. Pharmacol. 47, 713–716.
- Bourin, M., Guenzet, J. and Pradal, G. (1983) “La resorption des medicament par voie vaginale”, J. Gyn. Obst. Biol. Repr. 12, 717–726.
- British Pharmacopeae (1973) University of Printing House, London, UK.
- Buttar, H.S. (1985) “Fate of metronidazole following intravaginal and intravenous administration to rabbits”, Am. J. Obstet. Gynecol. 151, 705.
- Buttar, H.S. and Siddiqui, W.H. (1976) “Pharmacokinetics and metabolic disposition of 14C metronidazole derived radioactivity in rat after intravenous and intravaginal administration”, Arzneimittel-Forschung 26, 2054–2059.
- Cicinelli, E., Cignarelli, M. and Sabatelli, S. (1998) “Plasma concentrations of progesterone are higher in the uterine artery than in the radial artery after vaginal administration of micronized progesterone in an oil-based solution to postmenopausal women”, Fert. Steril. 69, 471–473.
- Cicinelli, E., Robini, G. and Ziegler, D.D. (2001) “Absorption and preferential vagina-to-uterus biodistribution after vaginal adminis- tration of 99mTc-pertechnetate in postmenopausal women”, Fertil. Steril. 76, 1108–1112.
- Corbo, D.C., Liu, J.C. and Chien, Y.W. (1990) “Characterization of the barrier properties of mucosal membranes”, J. Pharm. Sci. 79, 202–206.
- Cvetkovic, N., Rosic, M. and Trajkovic, S. (1998) “Comparative study of ribavirin transport through colon and vaginal epithelium”, Proc. 2nd World Meeting APGI/APV, 1045-1046, Paris.
- Deckart, H. and Cox, P.H. (1987) Principles of Radiopharmacy (Martinus Nijhoff Publishers, Boston), ISBN 0-89838-774-4.
- Fredricsson, B., Hangstro¨m, B. and Nord, C.E. (2001) “Systemic concentrations of metronidazole and its main metabolites after intravenous oral and vaginal administration”, Int. J. Gynecol. Obstet. 74, 35–43.
- Gjellan, K. and Graffner, C. (1994) “Comparative dissolution studies of rectal formulations using the basket, the paddle and the flow through methods: II. Ibuprofen in suppositories of both hydrophilic and lipophilic types”, Int. J. Pharm. 112, 233–240.
- Gonnet, J.F. and Guillot, J.P. (2001) Analysis Sertifcate Ovucire WL 3264, (Institut Franc¸ais de Researches et Essais Biologiques, Lyon, France).
- Hanff, L.M. and Rutten, W.J. (1996) “Pharmacokinetic aspects of rectal formulations of temazepam”, Pharm. World Sci. 18, 114–119.
- Higuchi, W.I. (1962) “Analysis data on the medicament release from ointments”, J. Pharm. Sci. 51, 802–804.
- Kolloffel, W.J. and Driessen, F.G. (1996) “Rectal administration of paracetamol: a comparison of a solution and suppositories in adult volunteers”, Pharm. World Sci. 18, 26–29.
- Liu, S., Edwards, D.S. and Barrett, J.A. (1997) “99mTc labeling of highly potent small peptides (Review)”, Bioconjugate Chem. 8, 621–636.
- Margarit, M.V. and Caballero, J.D. (2003) “Thermal and rheological study of lipophilic ethosaximide suppositories”, Eur. J. Pharm. Sci. 19, 123–128. Martindale (1989) The Extra Pharmacopoeia, 29th Ed. (The Pharma- ceutical Press, London, UK).
- Meseguer, G., Gurny, R. and Buri, P. (1994) “In-vivo evaluation of dosage forms-applications of gama-scintigraphy to non-enteral route of administration”, J. Drug Target. 2, 269–288.
- Nau, R., So¨rgel, F. and Prange, H.W. (1998) “Pharmacokinetic optimization of the treatment of bacterial central nervous system infections”, Clin. Pharmacokin. 35, 223–246.
- Ondracek, J., Stoll, B. and Kriftner, R. (1988) “New basket dissolution method for vaginal suppositories”, Acta Pharm. Technol. 34, 169–171.
- Plaxco, J.M., Free, C.B. and Rowland, C.R. (1967) “Effect of some nonionic surfactants on the rate of the release of drugs from suppositories”, J. Pharm. Sci. 56, 809–814.
- Remington’s Pharmaceutical Sciences (1990) Penysylvania, 18th Ed. (Mack Publishing Company, USA).
- Robbins, P.J. (1984) Chromatography of Technetium-99m Radio- pharmaceuticals. A practical guide (The Society of Nuclear Medicine Inc., New York).
- Roseman, T.J. (1981) “Continuous flow bead-bed apparatus for suppositories”, J. Pharm. Sci. 70, 646–651.
- Slovin, M. and Robinson, J.R. (1996) “Comparative per- meabilities of some solutes across the uterus, vagina and the vestibule of the rabbit doe”, S.T.P. Pharma Sci. 6, 430–434.
- Tanaka, M., Kuwahara, E. and Takahashi, M. (1998) “Effect of glycyrrhizinate on the dissolution behavior and rectal absorption of amphotericin B in rabbits”, Chem. Pharm. Bull. 21, 853–857.
- Taner, M.S., Ozdemir, D., Koseoglu, K. and Duman, Y. (2000) I. Eurasia Conference on Nuclear Science and Its Applications, Izmir/Turkey, 23-27.
- United States Pharmacopeia XXIII-NF XXVIII (1995) 23rd Rev., United States Pharmacopoeial Convention Rockville, USA.
- Vermani, K. and Garg, S. (2000) “The scope and potential of vaginal drug delivery”, PSTT 3, 359–364.
- Vidras, N.J., Reid, V.E., Bohidar, N.R. and Plakogiannis, F.M. (1982) “Medicament release from suppository bases I: Physicochemical characteristics and bioavailability of indomethacin in rabbits”, J. Pharm. Sci. 71, 945–949.
- Yang, D.J., Ilgan, S. and Higuchi, T. (1999) “Noninvasive assessment of tumor hypoxia with 99m Tc labeled metronidazole”, Pharm Res. 16, 743–750.